Cannabinoids for Medical Use
Penny Whiting1,2,3, Robert Wolff1, Sohan Deshpande1, Marcello Di Nisio4, Steven Duffy1, Adrían V. Hernández5,6, J. Christiaan Keurentjes7, Shona Lang1, Kate Misso1, Steve Ryder1, Simone Schmidlkofer8, Angela Wood1, Jos Kleijnen1,9
1Kleijnen Systematic Reviews Ltd, Escrick, York, United Kingdom
2School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom
3School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom2The National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West at University Hospitals, Bristol NHS Foundation Trust,
4Department of Medical, Oral, and Biotechnological Sciences, University “G. D'Annunzio” of Chieti-Pescara, Chieti, Italy5Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands
5Medical School, Universidad Peruana de Ciencias Aplicadas (UPC), Lima, Peru
6Medical School, Universidad Peruana de Ciencias Aplicadas (UPC), Lima, Peru7Health Outcomes and Clinical Epidemiology Section, Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio
7Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
8Institut für Epidemiologie und kongenitale Erkrankungen, Cepicon GmbH, Hamburg, Germany
9Kleijnen Systematic Reviews Ltd, Escrick, York, United Kingdom10School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, the Netherlands
Tóm tắt
Từ khóa
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
JAMA - Journal of the American Medical Association
Tập 313 Số 24
2456
Thông tin tác giả